Results overview: Found 4 records in 0.02 seconds.
Articles, 4 records found
Articles 4 records found  
1.
10 p, 310.2 KB Elevated Serum Triglyceride Levels in Acute Pancreatitis : A Parameter to be Measured and Considered Early / Hidalgo, Nils Jimmy (Hospital Universitari Vall d'Hebron) ; Pando, Elizabeth (Hospital Universitari Vall d'Hebron) ; Alberti Delgado, Piero (Hospital Universitari Vall d'Hebron) ; Vidal, Laura (Hospital Universitari Vall d'Hebron) ; Mata, Rodrigo (Hospital Universitari Vall d'Hebron) ; Fernandez, Nair (Hospital Universitari Vall d'Hebron) ; Gómez-Jurado, María José (Hospital Universitari Vall d'Hebron) ; Dopazo, Cristina (Hospital Universitari Vall d'Hebron) ; Blanco, Laia (Hospital Universitari Vall d'Hebron) ; Tasayco, Staphanie (Hospital Universitari Vall d'Hebron) ; Molero, Xavier (Hospital Universitari Vall d'Hebron) ; Balsells, Joaquim (Hospital Universitari Vall d'Hebron) ; Charco, Ramon (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona. Departament de Cirurgia
Background: The value of serum triglycerides (TGs) related to complications and the severity of acute pancreatitis (AP) has not been clearly defined. Our study aimed to analyze the association of elevated levels of TG with complications and the severity of AP. [...]
2022 - 10.1007/s00268-022-06533-w
World Journal of Surgery, 2022  
2.
13 p, 11.2 MB Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment : A case report / Mirallas, Oriol (Vall d'Hebron Institut d'Oncologia) ; Saoudi, Nadia (Vall d'Hebron Institut d'Oncologia) ; Gomez-Puerto, Diego (Vall d'Hebron Institut d'Oncologia) ; Riveiro Barciela, Mar (Hospital Universitari Vall d'Hebron) ; Merino, Xavier (Hospital Universitari Vall d'Hebron) ; Auger, Cristina (Hospital Universitari Vall d'Hebron) ; Landolfi, Stefania (Hospital Universitari Vall d'Hebron) ; Blanco, Laia (Hospital Universitari Vall d'Hebron) ; Garcia-Burillo, Amparo (Hospital Universitari Vall d'Hebron) ; Molero, Xavier (Hospital Universitari Vall d'Hebron) ; Salcedo, Maria-Teresa (Hospital Universitari Vall d'Hebron) ; Capdevila Castillón, Jaume (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Metastatic small bowel low-grade neuroendocrine tumors (NETs) have a good prognosis. Surgery is the only curative treatment; however, this may induce advanced liver disease, particularly in long-term survivor patients. [...]
2021 - 10.4254/wjh.v13.i5.611
World Journal of Hepatology, Vol. 13 (may 2021) , p. 611-619  
3.
18 p, 6.6 MB A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer / López de Maturana, Evangelina (Centro de Investigación Biomédica en Red de Cáncer) ; Rodríguez, Juan Antonio (Centre de Regulació Genòmica) ; Alonso, Lola (Centro de Investigación Biomédica en Red de Cáncer) ; Lao, Oscar (Centre de Regulació Genòmica) ; Molina-Montes, Esther (Centro de Investigación Biomédica en Red de Cáncer) ; Martín-Antoniano, Isabel Adoración (Centro de Investigación Biomédica en Red de Cáncer) ; Gómez-Rubio, Paulina (Centro de Investigación Biomédica en Red de Cáncer) ; Lawlor, Rita (University and Hospital Trust of Verona. ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics) ; Carrato, Alfredo (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Hidalgo, Manuel (Weill Cornell Medicine) ; Iglesias, Mar (Parc de Salut MAR de Barcelona) ; Molero, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Löhr, Matthias (Gastrocentrum, Karolinska Institutet and University Hospital) ; Michalski, Christopher (Martin-Luther-University Halle-WittenberHalle (Saale). Department of Visceral, Vascular and Endocrine Surgery) ; Perea, José (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; O'Rorke, Michael (The University of Iowa. College of Public Health) ; Barberà, Victor Manuel (Hospital General Universitario de Elche) ; Tardón, Adonina (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Farré, Antoni (Institut d'Investigació Biomèdica Sant Pau) ; Muñoz-Bellvís, Luís (Instituto de Investigación Biomédica de Salamanca) ; Crnogorac-Jurcevic, Tanja (Queen Mary University of London. Barts Cancer Institute, Centre for Molecular Oncology) ; Domínguez-Muñoz, Enrique (Complejo Hospitalario Universitario de Santiago de Compostela) ; Gress, Thomas (University Hospital of Giessen and Marburg (Alemanya)) ; Greenhalf, William (University of Liverpool. Department of Molecular and Clinical Cancer Medicine) ; Sharp, Linda (Newcastle University, Institute of Health & Society) ; Arnes, Luís (Columbia University Medical Center. Department of Systems Biology) ; Cecchini, Lluís (Parc de Salut MAR de Barcelona) ; Balsells, Joaquim (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Costello, Eithne (University of Liverpool. Department of Molecular and Clinical Cancer Medicine) ; Ilzarbe, Lucas (Parc de Salut MAR de Barcelona) ; Kleeff, Jörg (Martin-Luther-University Halle-WittenberHalle (Saale). Department of Visceral, Vascular and Endocrine Surgery) ; Kong, Bo (Technical University of Munich. Department of Surgery) ; Márquez, Mirari (Centro de Investigación Biomédica en Red de Cáncer) ; Mora Brugués, Josefina (Institut d'Investigació Biomèdica Sant Pau) ; O'Driscoll, Damian (University College Cork. National Cancer Registry Ireland and HRB Clinical Research Facility) ; Scarpa, Aldo (University and Hospital Trust of Verona. ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics) ; Ye, Weimin (Karolinska Institutet (Estocolm, Suècia). Department of Medical Epidemiology and Biostatistics) ; Yu, Jingru (Karolinska Institutet (Estocolm, Suècia). Department of Medical Epidemiology and Biostatistics) ; García-Closas, Montserrat (Centro Nacional de Investigaciones Oncológicas) ; Kogevinas, M.. (Hospital del Mar (Barcelona, Catalunya)) ; Rothman, Nathaniel (Centro Nacional de Investigaciones Oncológicas) ; Silverman, Debra T. (Centro Nacional de Investigaciones Oncológicas) ; Albanes, Demetrius (Centro Nacional de Investigaciones Oncológicas) ; Arslan, Alan A. (New York University School of Medicine. Department of Population Health) ; Beane-Freeman, Laura (Centro Nacional de Investigaciones Oncológicas) ; Bracci, Paige M. (University of California. Department of Epidemiology and Biostatistics) ; Brennan, Paul (International Agency for Research on Cancer (IARC)) ; Bueno-de-Mesquita, Bas (National Institute for Public Health and the Environment (RIVM). Deparment for Determinants of Chronic Diseases (DCD)) ; Buring, Julie (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Canzian, Federico (German Cancer Research Center (DKFZ. Genomic Epidemiology Group) ; Du, Margaret (Memorial Sloan Kettering Cancer Center) ; Gallinger, Steven (Sinai Health System. Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute) ; Gaziano, J. Michael (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Goodman, Phyllis J. (SWOG Statistical Center, Fred Hutchinson Cancer Research Center) ; Gunter, Marc (International Agency for Research on Cancer (IARC)) ; LeMarchand, Loic (University of Hawaii Cancer Center. Cancer Epidemiology Program) ; Li, Donghui (University of Texas MD Anderson Cancer Center) ; Neale, Rachael E. (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia). Population Health Department) ; Peters, Ulrika (Fred Hutchinson Cancer Research Center. Division of Public Health Sciences) ; Petersen, Gloria M. (Mayo Clinic College of Medicine. Department of Health Sciences Research) ; Risch, Harvey A. (Yale School of Public Health. Department of Chronic Disease Epidemiology) ; Sánchez, Maria José (Universidad de Granada) ; Shu, Xiao-Ou (Vanderbilt University School of Medicine. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center) ; Thornquist, Mark D. (Fred Hutchinson Cancer Research Center. Division of Public Health Sciences) ; Visvanathan, Kala (Mayo Clinic College of Medicine. Department of Health Sciences Research) ; Zheng, Wei (Vanderbilt University School of Medicine. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center) ; Chanock, Stephen (Centro Nacional de Investigaciones Oncológicas) ; Easton, Douglas F (University of Cambridge. Centre for Cancer Genetic Epidemiology) ; Wolpin, Brian M. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Stolzenberg-Solomon, Rachael Z. (Centro Nacional de Investigaciones Oncológicas) ; Klein, Alison P. (Johns Hopkins School of Medicine. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center) ; Amundadottir, Laufey T. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Marti-Renom, Marc A. (Universitat Pompeu Fabra. Centre de Regulació Genòmica (CRG-UPF)) ; Real, Francisco X (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Malats, Núria (Centro de Investigación Biomédica en Red de Cáncer)
Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4. [...]
2021 - 10.1186/s13073-020-00816-4
Genome Medicine, Vol. 13 (february 2021)  
4.
8 p, 975.7 KB Oleic acid chlorohydrin, a new early biomarker for the prediction of acute pancreatitis severity in humans / de Madaria, Enrique (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Molero, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bonjoch, Laia (Institut d'Investigacions Biomèdiques de Barcelona) ; Casas, Josefina (Institut de Química Avançada de Catalunya) ; Cárdenas Jaén, Karina (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Montenegro, Andrea (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Closa Autet, Daniel (Institut d'Investigacions Biomèdiques de Barcelona) ; Universitat Autònoma de Barcelona
The early prediction of the severity of acute pancreatitis still represents a challenge for clinicians. Experimental studies have revealed the generation of specific halogenated lipids, in particular oleic acid chlorohydrin, in the early stages of acute pancreatitis. [...]
2018 - 10.1186/s13613-017-0346-6
Annals of Intensive Care, Vol. 8 (january 2018)  

See also: similar author names
1 Molero, X.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.